Citation 65491

NAKANISHI,S: ANDO,K: KAWAMOTO,I: YASUZAWA,T: SANO,H: KASE,H:. (1989). KS-504 COMPOUNDS, NOVEL INHIBITORS OF CA2 AND CALMODULIN-DEPENDENT CYCLIC NUCLEOTIDE PHOSPHODIESTERASE FROM MOLLISIA VENTOSA.. 42(12)

Citation Details

TitleKS-504 COMPOUNDS, NOVEL INHIBITORS OF CA2 AND CALMODULIN-DEPENDENT CYCLIC NUCLEOTIDE PHOSPHODIESTERASE FROM MOLLISIA VENTOSA.
AuthorsNAKANISHI,S: ANDO,K: KAWAMOTO,I: YASUZAWA,T: SANO,H: KASE,H:
Year1989
Volume42
Issue12

Summary

Year: 1989

Journal: Unknown

Organisms and Their Experiments (1)

Mollisia ventosa (DERMATEACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDTLC DATA REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
MOLLISIA ANTIBIOTIC KS-504-A
None
2
TOXICITY ASSESSMENT(QUANTITATIVE)
PHARMACOLOGY OF COMPOUND - IN VIVO
MOLLISIA ANTIBIOTIC KS-504-A
.
3
CYCLIC NUCLEOTIDE PHOSPHODIESTERASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
MOLLISIA ANTIBIOTIC KS-504-A
ACTIVE
4
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLLISIA ANTIBIOTIC KS-504-A
ACTIVE
5
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLLISIA ANTIBIOTIC KS-504-A
WEAK ACTIVITY
6
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLLISIA ANTIBIOTIC KS-504-A
ACTIVE
7
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLLISIA ANTIBIOTIC KS-504-A
INACTIVE
8
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLLISIA ANTIBIOTIC KS-504-A
INACTIVE
9
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLLISIA ANTIBIOTIC KS-504-A
WEAK ACTIVITY
10
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLLISIA ANTIBIOTIC KS-504-A
INACTIVE
11
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLLISIA ANTIBIOTIC KS-504-A
INACTIVE
12
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLLISIA ANTIBIOTIC KS-504-A
INACTIVE
13
ANTIYEAST ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLLISIA ANTIBIOTIC KS-504-A
WEAK ACTIVITY
14Not specified
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDTLC DATA REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
MOLLISIA ANTIBIOTIC KS-504-B
None
15
TOXICITY ASSESSMENT(QUANTITATIVE)
PHARMACOLOGY OF COMPOUND - IN VIVO
MOLLISIA ANTIBIOTIC KS-504-B
.
16
CYCLIC NUCLEOTIDE PHOSPHODIESTERASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
MOLLISIA ANTIBIOTIC KS-504-B
ACTIVE
17
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLLISIA ANTIBIOTIC KS-504-B
ACTIVE
18
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLLISIA ANTIBIOTIC KS-504-B
WEAK ACTIVITY
19
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLLISIA ANTIBIOTIC KS-504-B
ACTIVE
20
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLLISIA ANTIBIOTIC KS-504-B
INACTIVE
21
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLLISIA ANTIBIOTIC KS-504-B
INACTIVE
22
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLLISIA ANTIBIOTIC KS-504-B
INACTIVE
23
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLLISIA ANTIBIOTIC KS-504-B
INACTIVE
24
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLLISIA ANTIBIOTIC KS-504-B
INACTIVE
25
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLLISIA ANTIBIOTIC KS-504-B
INACTIVE
26
ANTIYEAST ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLLISIA ANTIBIOTIC KS-504-B
WEAK ACTIVITY
27Not specified
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDTLC DATA REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
MOLLISIA ANTIBIOTIC KS-504-D
None
28
TOXICITY ASSESSMENT(QUANTITATIVE)
PHARMACOLOGY OF COMPOUND - IN VIVO
MOLLISIA ANTIBIOTIC KS-504-D
.
29
CYCLIC NUCLEOTIDE PHOSPHODIESTERASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
MOLLISIA ANTIBIOTIC KS-504-D
INACTIVE
30
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLLISIA ANTIBIOTIC KS-504-D
WEAK ACTIVITY
31
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLLISIA ANTIBIOTIC KS-504-D
INACTIVE
32
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLLISIA ANTIBIOTIC KS-504-D
ACTIVE
33
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLLISIA ANTIBIOTIC KS-504-D
INACTIVE
34
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLLISIA ANTIBIOTIC KS-504-D
INACTIVE
35
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLLISIA ANTIBIOTIC KS-504-D
INACTIVE
36
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLLISIA ANTIBIOTIC KS-504-D
INACTIVE
37
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLLISIA ANTIBIOTIC KS-504-D
INACTIVE
38
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLLISIA ANTIBIOTIC KS-504-D
INACTIVE
39
ANTIYEAST ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLLISIA ANTIBIOTIC KS-504-D
INACTIVE
40Not specified
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDTLC DATA REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
MOLLISIA ANTIBIOTIC KS-504-E
None
41
TOXICITY ASSESSMENT(QUANTITATIVE)
PHARMACOLOGY OF COMPOUND - IN VIVO
MOLLISIA ANTIBIOTIC KS-504-E
.
42
CYCLIC NUCLEOTIDE PHOSPHODIESTERASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
MOLLISIA ANTIBIOTIC KS-504-E
ACTIVE
43
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLLISIA ANTIBIOTIC KS-504-E
ACTIVE
44
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLLISIA ANTIBIOTIC KS-504-E
ACTIVE
45
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLLISIA ANTIBIOTIC KS-504-E
ACTIVE
46
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLLISIA ANTIBIOTIC KS-504-E
INACTIVE
47
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLLISIA ANTIBIOTIC KS-504-E
WEAK ACTIVITY
48
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLLISIA ANTIBIOTIC KS-504-E
ACTIVE
49
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLLISIA ANTIBIOTIC KS-504-E
INACTIVE
50
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLLISIA ANTIBIOTIC KS-504-E
ACTIVE
51
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLLISIA ANTIBIOTIC KS-504-E
INACTIVE
52
ANTIYEAST ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MOLLISIA ANTIBIOTIC KS-504-E
ACTIVE
Show SPARQL Queries (1)